Asston Pharmaceuticals Ltd (APL) — Stock Analysis

Asston Pharmaceuticals Ltd (NSE: APL), ISIN INE0SJX01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

APL last traded at ₹64.90 (+1.03%), with a 52-week range of ₹60.00 to ₹125.50 (as of 29 Jul 2026).

Shareholding as of Sep 2025: promoters 50.66%, FIIs 6.04%, DIIs 0.00%, mutual funds 0.00%.

EquiSense Score (ECS): 25/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.